Skip to Main Content

Paper Details

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines.
37
2021
B, B.1, B.1.1, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 Spike glycoprotein, Spike, Spike mutations, VUI202012/01, ancestral, mRNA-1273
Author NameAffiliation
Xiaoying ShenDuke University School of Medicine
Xiaoying ShenDuke Human Vaccine Institute, Duke University School of Medicine
Barton F HaynesDuke Human Vaccine Institute, Duke University School of Medicine
Barton F HaynesDuke University Medical Center
Nicolas W HengartnerLos Alamos National Laboratory
Bette KorberLos Alamos National Laboratory
David C MontefioriDuke University School of Medicine
David C MontefioriDuke Human Vaccine Institute, Duke University School of Medicine
  • 1 - 8

Datasets

Release 1.2